Kidron Miriam
SEC insider (Form 3/4/5 filer). CIK 0001409232. Chief Scientific Officer at ORAMED PHARMACEUTICALS INC. (ORMP) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies Kidron Miriam has filed insider reports for
- ORAMED PHARMACEUTICALS INC. (ORMP): Director, Officer, Chief Scientific Officer
- Lifeward Ltd. (LFWD): Director
Kidron Miriam
CIK: 0001409232
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect208.1K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
72K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
100K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
47K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
70K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
104K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect209.3K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
100K shares- - Mar 25, 2026LFWD
Lifeward Ltd.
AwardDirect7.7K shares- - Mar 17, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect119.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  ORMP ORAMED PHARMACEUTICALS INC. | Award | 208,125 | - | $0 | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 72,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 100,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 47,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 69,999 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 104,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 209,291 | - | $0 | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 100,000 | - | - | Direct |
| Mar 25, 2026 |  LFWD Lifeward Ltd. | Award | 7,657 | - | $0 | Direct |
| Mar 17, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 119,558 | - | $0 | Direct |
1-10 of 19 transactions